Clinical Trials Market Size, Share, By Services (Project Management, and Site Management, Medical Writing & Medical Monitoring, Laboratory Services, Clinical Data Management, and Others), Phase Type (Phase I, Phase II, Phase III, and Phase IV), Study Design (Interventional, Treatment Studies, Observational Studies, and Expanded Access), Indication (Autoimmune, Pain Management, Oncology, CNS Condition, Cardiovascular, Diabetes, Obesity, and Others), End-User (Hospitals, Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies, and Research Laboratories) and Region - Trends, Analysis, and Forecast till 2035

Clinical trials market size was valued at USD 92.5 Billion in 2025 and is expected to reach USD 171.3 Billion by 2035, growing at a CAGR of 7.0%

Clinical trials is a type of research study that tests medical treatments, drugs, devices and procedures work in humans. Clinical trials focus on to gather data for safety, effectiveness, and compare to current treatment. Clinical trials are conducted in Phase I, II, III, and IV, to tests the effectiveness of the treatment in a large group and monitor side effects. Clinical trials market includes all services, technologies, and organization that support the design, and management of clinical research studies. Clinical trials often regulated by government agencies, such as FDA, EMA and ethics committees to ensure patient safety and integrity of the data collected.

The growing focus on improving healthcare outcomes, and rising clinical trial complexity, is projected to growth of clinical trials market share. The growing adoption of decentralized, virtual clinical trials, which allow participants for remotely monitored, increasing focus on rare, orphan diseases, and integration of artificial intelligence, big data is expected to expansion of market share for clinical trials. The increasing demand for new treatments, the rise of personalized medicine, and advancement in medical technologies, is anticipated to drive of target market growth.